PF-Atlas › Drugs › sildenafil

sildenafil

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

VA Office of Research and Development

Overview

sildenafil is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 10 tracked IPF clinical trials.

sildenafil clinical trials

NCT00359736 (Phase 2)NCT00352482 (Phase 2)NCT00659529 (Phase 1)NCT01194232 (Phase 1)NCT02057458 (Phase 2)NCT00981747 (Phase 2)NCT02626182 (Phase 1)NCT01382368 (Phase 4)NCT00625079 (Phase 4)NCT06510322 (Early Phase 1)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about sildenafil for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.